Filing Details
- Accession Number:
- 0001209191-23-059683
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-26 16:29:30
- Reporting Period:
- 2023-12-22
- Accepted Time:
- 2023-12-26 16:29:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1601485 | Elicio Therapeutics Inc. | ELTX | Pharmaceutical Preparations (2834) | 113430072 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1977769 | Gkcc, Llc | 501 Silverside Road, Suite 87Ava Wilmington DE 19809 | No | No | Yes | No | |
1979324 | Yekaterina Chudnovsky | C/O Elicio Therapeutics, Inc. 451 D Street, 5Th Floor, Suite 501 Boston MA 02210 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-12-22 | 1,213,000 | $5.81 | 1,915,639 | No | 4 | P | Indirect | Held by GKCC, LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Held by GKCC, LLC |
Footnotes
- Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC.